Cytek Biosciences, Inc. (CTKB)
5.59
+0.16
(+2.95%)
USD |
NASDAQ |
Oct 23, 16:00
5.59
0.00 (0.00%)
After-Hours: 20:00
Cytek Biosciences Gross Profit Margin (Quarterly) : 58.87% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 58.87% |
| March 31, 2026 | 48.16% |
| December 31, 2025 | 52.92% |
| September 30, 2025 | 52.69% |
| June 30, 2025 | 52.34% |
| March 31, 2025 | 48.62% |
| December 31, 2024 | 58.55% |
| September 30, 2024 | 56.32% |
| June 30, 2024 | 54.56% |
| March 31, 2024 | 51.30% |
| December 31, 2023 | 56.75% |
| September 30, 2023 | 56.62% |
| June 30, 2023 | 56.67% |
| Date | Value |
|---|---|
| March 31, 2023 | 58.88% |
| December 31, 2022 | 60.36% |
| September 30, 2022 | 66.36% |
| June 30, 2022 | 61.16% |
| March 31, 2022 | 57.54% |
| December 31, 2021 | 60.77% |
| September 30, 2021 | 61.89% |
| June 30, 2021 | 64.93% |
| March 31, 2021 | 59.68% |
| December 31, 2020 | 63.52% |
| September 30, 2020 | 62.23% |
| June 30, 2020 | 43.22% |
| March 31, 2020 | 46.56% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 55.48% |
| Bio-Rad Laboratories, Inc. | 53.12% |
| Bruker Corp. | 49.65% |
| Danaher Corp. | 59.34% |
| Harvard Bioscience, Inc. | 51.96% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.06% |
| Return on Assets | -17.17% |
| Return on Invested Capital | -20.97% |
| Profit Margin (Quarterly) | -25.26% |
| Operating Margin (Quarterly) | -23.68% |
| Return on Net Operating Assets | -45.00% |